EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Parkin‐TLR4‐NLRP3 Axis Directs Melatonin to Alleviate Atrazine‐Induced Immune Impairment in Splenic Macrophages

Shuo Liu, Tian‐Ning Yang, Yu‐Xiang Wang, Xiang‐Yu Ma, Yu‐Sheng Shi, Yi Zhao, Jin‐Long Li

Journal of Pineal Research · 2024-11 · 76 (8)

DOI: 10.1111/jpi.70014 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Atrazine (ATR) is a widespread environmental herbicide that seriously affects agricultural work and human safety. Melatonin (MLT) as an endogenous neuroendocrine hormone is widely found in animals and plants, which have antioxidant and anti‐inflammatory effects. Pink1/Parkin‐mediated mitophagy keeps normal physiological processes by degrading damaged mitochondria in cells. Therefore, we investigated the potential role and mechanism of MLT in ATR‐induced toxic injury of the spleen. The results showed that MLT alleviated ATR‐induced unclear boundary between the white pulp and the red pulp of the spleen. It is also shown that ATR resulted in swollen mitochondria, partial extinction of mitochondrial membranes and cristae, and increased mitophagy under the action of MLT. ATR‐induced reactive oxygen species (ROS) activates the Pink1/Parkin pathway, which guides mitophagy development and then causes the activation of TLR4/NF‐κB inflammatory pathway. Meanwhile, these damages further exacerbated the production of NLRP3 inflammasomes, leading to spleen necrosis. Interestingly, these changes were improved after MLT treatment. Collectively, we found that MLT alleviates ATR‐induced immune impairment in splenic macrophages via regulating Parkin‐TLR4‐NLRP3 axis which elucidates the effect of melatonin on the spleen and provides a novel perspective on melatonin in splenic inflammatory injury treatment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →